Chronic IL-33 expression predisposes to virus-induced asthma exacerbations by increasing type 2 inflammation and dampening antiviral immunity

Journal of Allergy and Clinical Immunology

Volumn 141, Issue 5, 2018, Pages 1607-1619.e9

  Werder, Rhiannon B ^a,c   Zhang, Vivian ^a,c   Lynch, Jason P ^a   Snape, Natale ^b   Upham, John W ^a   Spann, Kirsten ^a,b   Phipps, Simon ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

antiviral; asthma; exacerbation; IL 33; rhinovirus

Indexed keywords

DEXAMETHASONE; INTERFERON; INTERLEUKIN 33;

AIRWAY EPITHELIUM CELL; ANIMAL EXPERIMENT; ARTICLE; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CD4+ T LYMPHOCYTE; CHRONICITY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; HELA CELL LINE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHINOVIRUS INFECTION; VIRUS PNEUMONIA; VIRUS REPLICATION;

EID: 85033460423     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2017.07.051     Document Type: Article

References (59)

1. Moffatt, M.F., Gut, I.G., Demenais, F., Strachan, D.P., Bouzigon, E., Heath, S., et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 363 (2010), 1211–1221.
2. Grotenboer, N.S., Ketelaar, M.E., Koppelman, G.H., Nawijn, M.C., Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology. J Allergy Clin Immunol 131 (2013), 856–865.
3. Savenije, O.E., Mahachie John, J.M., Granell, R., Kerkhof, M., Dijk, F.N., de Jongste, J.C., et al. Association of IL33–IL-1 receptor–like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. J Allergy Clin Immunol 134 (2014), 170–177.
4. Moussion, C., Ortega, N., Girard, J.P., The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’?. PLoS One, 3, 2008, e3331.
5. Pichery, M., Mirey, E., Mercier, P., Lefrancais, E., Dujardin, A., Ortega, N., et al. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol 188 (2012), 3488–3495.
6. Liew, F.Y., Girard, J.P., Turnquist, H.R., Interleukin-33 in health and disease. Nat Rev Immunol 16 (2016), 676–689.
7. Saravia, J., You, D., Shrestha, B., Jaligama, S., Siefker, D., Lee, G.I., et al. Respiratory syncytial virus disease is mediated by age-variable IL-33. PLoS Pathog, 11, 2015, e1005217.
8. Prefontaine, D., Lajoie-Kadoch, S., Foley, S., Audusseau, S., Olivenstein, R., Halayko, A.J., et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 183 (2009), 5094–5103.
9. Prefontaine, D., Nadigel, J., Chouiali, F., Audusseau, S., Semlali, A., Chakir, J., et al. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 125 (2010), 752–754.
10. Lee, H.Y., Rhee, C.K., Kang, J.Y., Byun, J.H., Choi, J.Y., Kim, S.J., et al. Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma. Exp Lung Res 40 (2014), 66–76.
11. McSorley, H.J., Blair, N.F., Smith, K.A., McKenzie, A.N., Maizels, R.M., Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy. Mucosal Immunol 7 (2014), 1068–1078.
12. Saglani, S., Lui, S., Ullmann, N., Campbell, G.A., Sherburn, R.T., Mathie, S.A., et al. IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J Allergy Clin Immunol 132 (2013), 676–685 e13.
13. Barnes, P.J., New therapies for asthma: is there any progress?. Trends Pharmacol Sci 31 (2010), 335–343.
14. Jackson, D.J., Makrinioti, H., Rana, B.M., Shamji, B.W., Trujillo-Torralbo, M.B., Footitt, J., et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med 190 (2014), 1373–1382.
15. Stein, R.T., Sherrill, D., Morgan, W.J., Holberg, C.J., Halonen, M., Taussig, L.M., et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354 (1999), 541–545.
16. James, K.M., Gebretsadik, T., Escobar, G.J., Wu, P., Carroll, K.N., Li, S.X., et al. Risk of childhood asthma following infant bronchiolitis during the respiratory syncytial virus season. J Allergy Clin Immunol 132 (2013), 227–229.
17. Sigurs, N., Bjarnason, R., Sigurbergsson, F., Kjellman, B., Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 161 (2000), 1501–1507.
18. Carroll, K.N., Wu, P., Gebretsadik, T., Griffin, M.R., Dupont, W.D., Mitchel, E.F., et al. The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. J Allergy Clin Immunol 123 (2009), 1055–1061 e1.
19. Jackson, D.J., Evans, M.D., Gangnon, R.E., Tisler, C.J., Pappas, T.E., Lee, W.M., et al. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med 185 (2012), 281–285.
20. Stern, D.A., Morgan, W.J., Wright, A.L., Guerra, S., Martinez, F.D., Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 370 (2007), 758–764.
21. O'Byrne, P.M., Pedersen, S., Lamm, C.J., Tan, W.C., Busse, W.W., Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 179 (2009), 19–24.
22. Lynch, J.P., Werder, R.B., Simpson, J., Loh, Z., Zhang, V., Haque, A., et al. Aeroallergen-induced IL-33 predisposes to respiratory virus-induced asthma by dampening antiviral immunity. J Allergy Clin Immunol 138 (2016), 1326–1337.
23. Byers, D.E., Alexander-Brett, J., Patel, A.C., Agapov, E., Dang-Vu, G., Jin, X., et al. Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest 123 (2013), 3967–3982.
24. Papadopoulos, N.G., Christodoulou, I., Rohde, G., Agache, I., Almqvist, C., Bruno, A., et al. Viruses and bacteria in acute asthma exacerbations—a GA(2) LEN-DARE systematic review. Allergy 66 (2011), 458–468.
25. Johnston, S.L., Pattemore, P.K., Sanderson, G., Smith, S., Lampe, F., Josephs, L., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310 (1995), 1225–1229.
26. Message, S.D., Laza-Stanca, V., Mallia, P., Parker, H.L., Zhu, J., Kebadze, T., et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A 105 (2008), 13562–13567.
27. Wark, P.A., Johnston, S.L., Bucchieri, F., Powell, R., Puddicombe, S., Laza-Stanca, V., et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201 (2005), 937–947.
28. Contoli, M., Message, S.D., Laza-Stanca, V., Edwards, M.R., Wark, P.A., Bartlett, N.W., et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 12 (2006), 1023–1026.
29. Davidson, S., Kaiko, G., Loh, Z., Lalwani, A., Zhang, V., Spann, K., et al. Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway. J Immunol 186 (2011), 5938–5948.
30. Papi, A., Johnston, S.L., Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J Biol Chem 274 (1999), 9707–9720.
31. Kaiko, G.E., Loh, Z., Spann, K., Lynch, J.P., Lalwani, A., Davidson, S., et al. TLR7 gene deficiency and early-life Pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice. J Allergy Clin Immunol 131 (2013), 1331–1339.
32. Coyle, A.J., Lloyd, C., Tian, J., Nguyen, T., Erikkson, C., Wang, L., et al. Crucial role of the interleukin 1 receptor family member T1/St2 in T helper cell type 2–mediated lung mucosal immune responses. J Exp Med 190 (1999), 895–902.
33. Ullah, M.A., Loh, Z., Gan, W.J., Zhang, V., Yang, H., Li, J.H., et al. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation. J Allergy Clin Immunol 134 (2014), 440–450.
34. Oczypok, E.A., Milutinovic, P.S., Alcorn, J.F., Khare, A., Crum, L.T., Manni, M.L., et al. Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells. J Allergy Clin Immunol 136 (2015), 747–756 e4.
35. Tuthill, T.J., Papadopoulos, N.G., Jourdan, P., Challinor, L.J., Sharp, N.A., Plumpton, C., et al. Mouse respiratory epithelial cells support efficient replication of human rhinovirus. J Gen Virol 84 (2003), 2829–2836.
36. Edwards, M.R., Regamey, N., Vareille, M., Kieninger, E., Gupta, A., Shoemark, A., et al. Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol 6 (2013), 797–806.
37. Parsons, K.S., Hsu, A.C., Wark, P.A., TLR3 and MDA5 signalling, although not expression, is impaired in asthmatic epithelial cells in response to rhinovirus infection. Clin Exp Allergy 44 (2014), 91–101.
38. Baraldo, S., Contoli, M., Bazzan, E., Turato, G., Padovani, A., Marku, B., et al. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J Allergy Clin Immunol 130 (2012), 1307–1314.
39. Stewart, A., More muscle in asthma, but where did it come from?. Am J Respir Crit Care Med 185 (2012), 1035–1037.
40. James, A.L., Elliot, J.G., Jones, R.L., Carroll, M.L., Mauad, T., Bai, T.R., et al. Airway smooth muscle hypertrophy and hyperplasia in asthma. Am J Respir Crit Care Med 185 (2012), 1058–1064.
41. Christianson, C.A., Goplen, N.P., Zafar, I., Irvin, C., Good, J.T. Jr., Rollins, D.R., et al. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J Allergy Clin Immunol 136 (2015), 59–68 e14.
42. Pauwels, R.A., Pedersen, S., Busse, W.W., Tan, W.C., Chen, Y.Z., Ohlsson, S.V., et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 361 (2003), 1071–1076.
43. Castro, M., Zangrilli, J., Wechsler, M.E., Bateman, E.D., Brusselle, G.G., Bardin, P., et al. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med 3 (2015), 355–366.
44. Bel, E.H., Wenzel, S.E., Thompson, P.J., Prazma, C.M., Keene, O.N., Yancey, S.W., et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med 371 (2014), 1189–1197.
45. Djukanovic, R., Harrison, T., Johnston, S.L., Gabbay, F., Wark, P., Thomson, N.C., et al. The effect of inhaled IFN-beta on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med 190 (2014), 145–154.
46. Kumar, R.K., Herbert, C., Foster, P.S., Mouse models of acute exacerbations of allergic asthma. Respirology 21 (2016), 842–849.
47. Bartlett, N.W., Walton, R.P., Edwards, M.R., Aniscenko, J., Caramori, G., Zhu, J., et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med 14 (2008), 199–204.
48. Beale, J., Jayaraman, A., Jackson, D.J., Macintyre, J.D.R., Edwards, M.R., Walton, R.P., et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med, 6, 2014, 256ra134.
49. Rochlitzer, S., Hoymann, H.G., Muller, M., Braun, A., No exacerbation but impaired anti-viral mechanisms in a rhinovirus-chronic allergic asthma mouse model. Clin Sci (Lond) 126 (2014), 55–65.
50. Clarke, D.L., Davis, N.H., Majithiya, J.B., Piper, S.C., Lewis, A., Sleeman, M.A., et al. Development of a mouse model mimicking key aspects of a viral asthma exacerbation. Clin Science (Lond) 126 (2014), 567–580.
51. Phan, J.A., Kicic, A., Berry, L.J., Fernandes, L.B., Zosky, G.R., Sly, P.D., et al. Rhinovirus exacerbates house-dust-mite induced lung disease in adult mice. PLoS One, 9, 2014, e92163.
52. Newcomb, D.C., Boswell, M.G., Reiss, S., Zhou, W., Goleniewska, K., Toki, S., et al. IL-17A inhibits airway reactivity induced by respiratory syncytial virus infection during allergic airway inflammation. Thorax 68 (2013), 717–723.
53. Longphre, M., Li, D., Gallup, M., Drori, E., Ordonez, C.L., Redman, T., et al. Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest 104 (1999), 1375–1382.
54. Spann, K.M., Baturcam, E., Schagen, J., Jones, C., Straub, C.P., Preston, F.M., et al. Viral and host factors determine innate immune responses in airway epithelial cells from children with wheeze and atopy. Thorax 69 (2014), 918–925.
55. Bochkov, Y.A., Hanson, K.M., Keles, S., Brockman-Schneider, R.A., Jarjour, N.N., Gern, J.E., Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol 3 (2010), 69–80.
56. Lopez-Souza, N., Favoreto, S., Wong, H., Ward, T., Yagi, S., Schnurr, D., et al. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol 123 (2009), 1384–1390 e2.
57. Davidson, S., Kaiko, G., Loh, Z., Lalwani, A., Zhang, V., Spann, K., et al. Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway. J Immunol 186 (2011), 5938–5948.
58. Lynch, J.P., Werder, R.B., Simpson, J., Loh, Z., Zhang, V., Haque, A., et al. Aeroallergen-induced IL-33 predisposes to respiratory virus-induced asthma by dampening antiviral immunity. J Allergy Clin Immunol 138 (2016), 1326–1337.
59. Kaiko, G.E., Loh, Z., Spann, K., Lynch, J.P., Lalwani, A., Davidson, S., et al. TLR7 gene deficiency and early-life Pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice. J Allergy Clin Immunol 131 (2013), 1331–1339.